Positioning and sequencing of advanced therapies in inflammatory bowel disease: A guide for clinical practice

Figure 1 Considerations in positioning and sequencing advanced therapies in inflammatory bowel disease. IBD: Inflammatory bowel disease. Image created with BioRender.

Figure 2 Factors beyond clinical phenotype and disease activity that guide therapy selection. JAK: Janus kinase. Image created with BioRender.

Figure 3 Inflammatory bowel disease treatment guide: Preferred, alternative, and avoidable medications by patient profile. EIM: Extraintestinal manifestation; HF: Heart failure; NYHA: New York Heart Association; TNF: Tumoral necrosis factor; S1P: Sphingosine 1-phosphate; JAK: Janus kinase; PsA: Psoriatic arthritis; PsO: Psoriasis. Image created with BioRender.